31 Aug

BioLife Solutions Executes Supply Agreement with Celyad

BioLife Solutions Executes Supply Agreement with Celyad for CryoStor® Use in Natural Killer Receptor based T-Cell (NKR-T) Platform Targeting Solid Tumors and Blood Cancers Proprietary Clinical Grade Cell Freeze Media Enables Long-Term Storage and Distribution of Engineered Cell-Based Therapies BioLife is pleased to announce that it has executed a long term supply agreement with NASDAQ-listed Celyad, […]

read more »
19 Jul

BioLife Solutions CryoStor® Cell Freeze Media Embedded in Invossa™: First Approved Cell and Gene Therapy for Osteoarthritis

Korean Approval Received by Kolon Life Science, TissueGene’s Exclusive Licensee BioLife Solutions, Inc. (NASDAQ: BLFS), the leading supplier of pre-formulated, clinical grade cell and tissue hypothermic storage and cryopreservation freeze media (“BioLife”), announced on July 13th 2017 that Kolon Life Science, TissueGene’s exclusive licensee for Asia, including Korea, has received marketing approval for Invossa-K Inj., the world’s […]

read more »
15 Feb

BioLife Solutions’ Joint Venture Partner SAVSU Technologies Provides Performance Update on evo® Cold Chain 2.0™ System in ImmunoCellular Therapeutics Phase 3 Glioblastoma Cell Therapy Clinical Trial

ImmunoCellular Therapeutics has successfully deployed SAVSU’s evo® Cold Chain 2.0™ software-as-a-service (SaaS) live cell visibility platform to pack, ship, track and monitor apheresis units from point of collection to cell therapy manufacturing sites. Cellular immunotherapy ICT-107 is a patient-specific autologous dendritic cell immunotherapy under evaluation to treat study patients with glioblastoma in Phase 3 clinical […]

read more »
03 Nov

BioLife Solutions to Present at 4th Annual European Advanced Therapies Investor Day

BioLife’s CEO Mike Rice will be presenting at the 4th Annual European Advanced Therapies Day on November 3rd at 30 Euston Square, London, England. This one-day, invitation-only meeting provides institutional, corporate and private investors with unique insight into the investment hypothesis for advanced therapies-based treatments and tools. The program includes talks by large pharmaceutical and enabling […]

read more »
18 Apr

Ambient Temp Is Not True Payload Temp!

Sensor based logistics for temperature-sensitive shipments can provide meaningful and actionable data, IF you are measuring the right stuff. Toss in the box GPS-based sensors purport to monitor payload temperature, but significant gradients can exist between the biologic payload temperature and the interior of the shipping container. In the tightly regulated 2-8°C environment, an excursion of a degree or two above or below this range might mean the difference between cells arriving alive and functional vs. dying or dead. Your patients deserve better!

read more »